Neuralstem Inc. (CUR) Stock Research, Analysis & News

Quick Analysis on Neuralstem Inc. (CUR) Stock as of December 11, 2017

The Stock pays no dividend
Average trading volume is relatively low at 0
(See more information about Neuralstem Inc. (CUR) Stock below)

Neuralstem Inc. (CUR) Stock Profile Summary

Neuralstem, Inc., a biopharmaceuticals company, focuses on the development and commercialization of treatments for central nervous system diseases based on transplanting human neural stem cells and small molecule drugs. It uses its proprietary human neural stem cell technology as a tool for use in the small-molecule drug discovery, as well as to create cell therapy biotherapeutics for the treatment of central nervous system diseases, various neurodegenerative conditions, and for the regenerative repair of acute diseases. The company was founded in 1996 and is headquartered in Rockville, Maryland.

Neuralstem Inc. (CUR) Stock Key Statistics Research and Analysis as of December 11, 2017

Latest Market News on Neuralstem Inc. (CUR)


Click here to find the latest news on Neuralstem Inc. (CUR)

Looking for Market Opportunties?


Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center